Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs GSK✓SelectedUSD · GSKMRNA vs GSK performance historyLatest closeAs of+1.29%11/19
Stock and ETF performance explorer

MRNA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+971.7%
GSK return
+83.0%
Excess return
+888.7%
Maximum drawdown
-95.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.3%-1.6%+2.9%+2.2%
7D-13.8%-4.7%-9.1%-11.4%
30D-17.7%-4.7%-13.0%-15.5%
3M+14.3%-8.8%+23.1%+20.9%
6M+336.0%-4.6%+340.6%+355.0%
YTD+575.9%+1.0%+574.9%+586.2%
1Y+724.4%+6.9%+717.5%+718.1%
3Y+160.8%+52.5%+108.2%+125.1%
5Y-24.4%+40.3%-64.7%-34.0%
All+971.7%+83.0%+888.7%+618.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling